The depression which does not respond or shows any sign of improvement when treated with an antidepressant is known as a treatment-resistance depression treatment. In [read full press release…]
The hospitalized rate is high in the population with treatment-resistance depression treatment. Thus, the hospitalized cost burden is 5-6 times higher than those with major [read full press release…]
This rising prevalence of treatment-resistance depression treatment will boost the market for the Treatment-Resistance Depression Treatment Market. It has been observed that a few populations [read full press release…]
The increasing prevalence of depression and anxiety-related disorders in adults, as well as the aging population, is the major factor contributing to the growth of [read full press release…]
This rising prevalence of treatment-resistance depression treatment will boost the market for the Treatment-Resistance Depression Treatment Market. It has been observed that a few populations [read full press release…]
